Back to Directory

Justine Beck

Email

Justine.beck@nih.gov

Phone

301-761-5288

Institution

PAB, DAIDS, NIAID, NIH

Address

Pharmaceutical Affairs Branch
5601 Fishers Lane
MSC 9829
Rockville, MD 20852

Request an Update

Affiliated Studies

IMPAACT 2023: A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

DAIDS Number

Research Area

Study Status

Closed to Follow Up

IMPAACT 2039A: Phase I Study of the Safety and Immunogenicity of HIVconsvX Vaccines and the Safety and Pharmacokinetics of Broadly Neutralizing Antibodies in Children Living with HIV

DAIDS Number

Research Area

Cure and Immunotherapy

IMPAACT 2042: Tatelo Plus

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status

IMPAACT 2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination with Optimized Multidrug Background Regimen (OBR) in Children with MDR-TB with and without HIV

DAIDS Number

Research Area

Study Status

Closed to Follow Up

Show All